Evidence map›Paper›PMID 41509863›Full record

ArticleFrontiers in cellular and infection microbiology2025

Association between

Caihua Yang, Haoxuan Jiang, Linyan Li, Ping Zheng, Yilei Li, Ying Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caihua Yang *Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Haoxuan Jiang *School of Biomedical Engineering, Hainan University, Sanya, China.
Linyan LiClinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ping ZhengClinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yilei LiClinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ying WuDepartment of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: After COVID-19 pandemic, there has been an upward trend in Methods: We conducted a single-center cohort study in Guangzhou, China, from February 2023 to June 2024, involving pregnant women. A total of 186 participants were included, with 49 in the Results: The incidence of adverse pregnancy outcomes in the Conclusions: In the post-COVID-19 era, evidence remains insufficient to conclude that

Indexed as

Pneumonia, MycoplasmaPregnancy Complications, InfectiousPregnancy OutcomeAdultAntibodies, BacterialChinaCohort StudiesCOVID-19FemaleHumansImmunoglobulin MIncidenceMycoplasma pneumoniaePregnancyPropensity ScoreAntibodies, BacterialImmunoglobulin Madvanced maternal ageCOVID-19Mycoplasma pneumoniaepregnancypropensity score

Identifiers

PMID41509863
PMCPMC12775152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.